# V1 Empirics Check — google/gemini-3-flash-preview (Variant B)

**Model:** google/gemini-3-flash-preview
**Variant:** B
**Date:** 2026-03-27T00:36:41.737410

---

**Referee Review**

**Title:** The Pasteurization Illusion: Why Cross-Sectional Evidence Overstates Raw Milk Risk
**Paper ID:** idea_1659
**Reviewer:** Expert Referee (Empirical Economics)

---

### 1. Idea Fidelity
The paper aligns closely with the original idea manifest. It successfully executes the proposed identification strategy (Staggered DiD using Poisson PPML and Callaway-Sant’Anna) and utilizes the specified data source (CDC NORS via Socrata). It follows the suggested timeline (1998–2023) and incorporates the 30+ state-level legal changes. The paper expands on the manifest by explicitly naming the "Pasteurization Illusion"—the discrepancy between cross-sectional and panel estimates—which adds a layer of conceptual depth to the original proposal.

### 2. Summary
This paper evaluates the causal impact of state-level raw milk legalization on foodborne illness outbreaks using a 26-year panel of US states. While prior cross-sectional studies suggest a 3.8-fold increase in risk, this study uses staggered difference-in-differences to show that legalization results in a much smaller, statistically insignificant increase (approx. 40%). The author concludes that the perceived risk in cross-sectional data is largely driven by selection bias—states with high dairy production and strong surveillance are more likely to both legalize raw milk and report outbreaks.

### 3. Essential Points
1.  **Statistical Power and Null Results:** The paper’s central claim is that the effect is "modest" and "an order of magnitude smaller" than previous estimates. However, the 95% confidence interval for the primary Poisson estimate (Column 1, Table 2) includes an increase of up to 174%. Given that the point estimate is a 40% increase and the standard error is large, the paper must more carefully distinguish between "the effect is small" and "the estimate is too imprecise to rule out large effects." The author should provide a formal power analysis or a "Minimum Detectable Effect" (MDE) to justify the conclusion that the risk is definitively lower than previously thought.
2.  **Treatment Intensity and Timing:** The "Legal" indicator collapses highly heterogeneous policies (retail vs. herdshare). While Table 4, Panel C begins to address this, the main results treat a state legalizing retail sales and a state legalizing a niche herdshare agreement as the same treatment. Furthermore, the timing of "legalization" in the data (Appendix C) often lists the year of a court ruling or a policy change, but the actual market entry of raw milk can lag or lead these dates. The author must verify if the "always legal" states (like CA or PA) experienced any significant regulatory shifts entering the sample that might contaminate the control group in the TWFE specification.
3.  **Surveillance Bias as an Endogenous Response:** The paper acknowledges that "states that legalize may simultaneously invest in outbreak detection." If legalization *causes* better reporting, the PPML estimate is biased upward. If legalization is *caused* by a culture that also reports more, it is a selection issue. The placebo test on non-dairy outbreaks (Table 4) shows a coefficient of 0.208 ($p=0.14$). This is uncomfortably close to the main effect of 0.339. The author needs to perform a more rigorous test (e.g., a triple-difference using non-dairy outbreaks as a within-state control) to isolate the milk-specific effect from the general surveillance trend.

### 4. Suggestions

**Data and Measurement**
*   **Exposure Weighting:** The current model treats all states as equal units. However, an outbreak in California involves a much larger "at-risk" population than one in Wyoming. I strongly suggest weighting the Poisson regressions by state population or, preferably, using state milk production volume as an offset/exposure variable to account for the underlying probability of dairy-related issues.
*   **Pathogen-Specific Analysis:** Not all raw milk outbreaks are equal. *Campylobacter* is frequently associated with raw milk, while *Salmonella* can often be found in pasteurized milk due to post-processing contamination. Repeating the analysis specifically for *Campylobacter* would strengthen the causal claim that the observed effects are truly linked to the raw milk policy.
*   **Zero-Inflation:** Using PPML is standard, but given that 85% of state-years have zero outbreaks, a Zero-Inflated Poisson (ZIP) model might better capture the dual process of (1) having a raw milk market and (2) having an outbreak occur within that market.

**Identification Strategy**
*   **Stacking or Imputation:** While the paper uses Callaway-Sant'Anna (CS), the main results rely on TWFE Poisson. Recent literature (Gardner, 2021; Borusyak et al., 2024) shows TWFE can be biased in the presence of staggered treatment even in non-linear models. I recommend using the "stacked" DiD approach for the Poisson model to ensure the TWFE "forbidden comparisons" are not driving the 0.339 coefficient.
*   **The "Always Legal" Group:** The paper includes 24 "always legal" states in the TWFE. These states may have very different trends than the "never legal" states. I suggest a robustness check that excludes the "always legal" states entirely to see if the newly-treated states' dynamics are identified solely against the "never legal" group.

**Interpretation and Presentation**
*   **The H5N1 Narrative:** The introduction and conclusion lean heavily on the 2024 H5N1 outbreak. Since the data ends in 2023, the paper cannot actually estimate the effect of H5N1. This framing is useful for "Insights" but should be explicitly labeled as speculative/contextual.
*   **Visualizing the "Illusion":** A figure comparing the cross-sectional correlation (a simple scatter plot of Legal Status vs. Mean Outbreaks) alongside the event study would be highly effective for an AER: Insights format. It would visually demonstrate the "Pasteurization Illusion" by showing the level shift between groups that disappears once fixed effects are applied.
*   **Table 3 (Event Study):** The $t-6$ and $t-4$ coefficients are statistically significant and negative. This suggests a potential violation of parallel trends or an issue with the composition of the treatment/control groups in those specific years. The author should investigate which states are driving these early pre-trend negatives.
*   **Clustering:** With only 51 jurisdictions (and only 15-17 moving units), the cluster-robust standard errors might be undersized. I recommend reporting wild bootstrap p-values to confirm the levels of significance.
